| 000 | 01591 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514071543.0 | ||
| 264 | 0 | _c20031027 | |
| 008 | 200310s 0 0 eng d | ||
| 022 | _a0767-3981 | ||
| 024 | 7 |
_a10.1046/j.1472-8206.2003.00137.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe La Cruz, J P | |
| 245 | 0 | 0 |
_aDifferences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers. _h[electronic resource] |
| 260 |
_bFundamental & clinical pharmacology _cJun 2003 |
||
| 300 |
_a363-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAspirin _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aDinoprost _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEpoprostenol _xagonists |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitric Oxide _xagonists |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aSalicylic Acid _xblood |
| 650 | 0 | 4 |
_aThromboxane B2 _xantagonists & inhibitors |
| 700 | 1 | _aGonzález-Correa, J A | |
| 700 | 1 | _aGuerrero, A | |
| 700 | 1 | _aMárquez, E | |
| 700 | 1 | _aMartos, F | |
| 700 | 1 | _aSánchez De La Cuesta, F | |
| 773 | 0 |
_tFundamental & clinical pharmacology _gvol. 17 _gno. 3 _gp. 363-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1472-8206.2003.00137.x _zAvailable from publisher's website |
| 999 |
_c12587955 _d12587955 |
||